Cytokinetics
CYTK
#2378
Rank
NZ$13.36 B
Marketcap
NZ$109.30
Share price
1.92%
Change (1 day)
33.28%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: NZ$13.36 Billion

As of January 2026 Cytokinetics has a market cap of NZ$13.36 Billion. This makes Cytokinetics the world's 2378th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$13.36 B0.3%
2025NZ$13.32 B34.44%
2024NZ$9.91 B-23.44%
2023NZ$12.94 B89.55%
2022NZ$6.82 B21.27%
2021NZ$5.63 B176.28%
2020NZ$2.03 B118.67%
2019NZ$0.93 B80.82%
2018NZ$0.51 B-16.63%
2017NZ$0.61 B-13.2%
2016NZ$0.71 B17.77%
2015NZ$0.60 B53.06%
2014NZ$0.39 B62.85%
2013NZ$0.24 B112.34%
2012NZ$0.11 B28.55%
2011NZ$88.9 M-50.95%
2010NZ$0.18 B-26.17%
2009NZ$0.24 B0.1%
2008NZ$0.24 B-19.41%
2007NZ$0.30 B-33.78%
2006NZ$0.45 B78.91%
2005NZ$0.25 B-33.39%
2004NZ$0.38 B

End of Day market cap according to different sources

On Jan 19th, 2026 the market cap of Cytokinetics was reported to be:

NZ$13.11 Billion
by Nasdaq info icon info icon
NZ$13.11 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$6.62 B-50.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
NZ$0.01 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.4 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.44 B 2,185.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ$2.57 B-80.73%๐Ÿ‡บ๐Ÿ‡ธ USA